Brain Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy Findings of Children with Kernicterus

Summary Background The term kernicterus, or bilirubin encephalopathy, is used to describe pathological bilirubin staining of the basal ganglia, brain stem, and cerebellum, and is associated with hyperbilirubinemia. Kernicterus generally occurs in untreated hyperbilirubinemia or cases where treatment is delayed. Magnetic resonance imaging (MRI)-based studies have shown characteristic findings in kernicterus. The objective of our study was to describe the role of 1H magnetic resonance spectroscopy (MRS) in demonstrating these metabolic changes and to review conventional MRI findings of kernicterus. Material/Methods Forty-eight pediatric cases with kernicterus were included in this study. MRI and MRS examinations were performed on variable dates (10–29 days after birth). NAA, Cr, Cho, NAA/Cr, NAA/Cho, and Cho/Cr values were evaluated visually and by computer analysis. Results There was no statistically significant difference between the NAA and Cho levels in the acute kernicterus patients and the control group (healthy patients), whereas both were significantly elevated in the chronic kernicterus patients. Both the mean NAA/Cr and Cho/Cr ratio values were significantly higher in the acute and chronic cases compared to the control group. The NAA/Cho ratio value was statistically lower in the acute cases than in the control group while it was similar in the chronic cases. Conclusions Conventional MR imaging and 1H-MRS are important complementary tools in the diagnostics of neonatal bilirubin encephalopathy. This study provided important information for applying these MR modalities in the evaluation of neonates with bilirubin encephalopathy.

[1]  Mingwu Lou,et al.  Usefulness of 1H‐MRS in differentiating bilirubin encephalopathy from severe hyperbilirubinemia in neonates , 2013, Journal of magnetic resonance imaging : JMRI.

[2]  K. Yokochi.  Magnetic resonance imaging in children with kernicterus , 1995, Acta paediatrica.

[3]  S. Mirowitz,et al.  Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition. , 1991, Radiology.

[4]  P. Joseph,et al.  Choroidal melanomas: correlation of NMR spectroscopy and MR imaging. , 1986, Radiology.

[5]  M. Lequin,et al.  Changes in globus pallidus with (pre)term kernicterus. , 2003, Pediatrics.

[6]  K. Sartor,et al.  High-intensity basal ganglia lesions on T1-weighted MR images in neurofibromatosis. , 1989, AJNR. American journal of neuroradiology.

[7]  R. Wennberg.  The Blood–Brain Barrier and Bilirubin Encephalopathy , 2000, Cellular and Molecular Neurobiology.

[8]  S. Kollias,et al.  MR findings in kernicterus. , 1995, AJNR. American journal of neuroradiology.

[9]  M. Noseworthy,et al.  1H MR spectroscopic characteristics of kernicterus: a possible metabolic signature. , 2005, AJNR. American journal of neuroradiology.

[10]  R. Cremer,et al.  INFLUENCE OF LIGHT ON THE HYPERBILIRUBINÆMIA OF INFANTS , 1958 .

[11]  S. Shapiro,et al.  Bilirubin toxicity in the developing nervous system. , 2003, Pediatric neurology.

[12]  R. Zimmerman,et al.  Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. , 2001, Pediatrics.

[13]  C. Miller,et al.  A clinical pathologic reappraisal of kernicterus. , 1982, Pediatrics.

[14]  A. Newman,et al.  HYPERBILIRUBINEMIA IN BREAST-FED INFANTS. , 1963, Pediatrics.

[15]  M. Reiser,et al.  MR findings in a patient with Kernicterus , 1999, European Radiology.

[16]  Ping Zhang,et al.  Studying neonatal bilirubin encephalopathy with conventional MRI, MRS, and DWI , 2008, Neuroradiology.

[17]  C Boesch,et al.  Brain metabolite composition during early human brain development as measured by quantitative in vivo 1H magnetic resonance spectroscopy , 2002, Magnetic resonance in medicine.

[18]  A. Brown,et al.  Lack of predictive indices in kernicterus: a comparison of clinical and pathologic factors in infants with or without kernicterus. , 1980, Pediatrics.

[19]  M. Johnston,et al.  Role of Glutamate Receptor-Mediated Excitotoxicity in Bilirubin-Induced Brain Injury in the Gunn Rat Model , 1998, Experimental Neurology.

[20]  V. Koziel,et al.  Bilirubin Induces Apoptosis via Activation of NMDA Receptors in Developing Rat Brain Neurons , 2000, Experimental Neurology.

[21]  P. Labrune.  Ictère grave du nouveau-né. Définition et prise en charge , 1998 .

[22]  M. Segal,et al.  Quantitative analysis of MR images in asphyxiated neonates: correlation with neurodevelopmental outcome. , 2001, AJNR. American journal of neuroradiology.

[23]  J. Lucey,et al.  TRANSIENT FAMILIAL NEONATAL HYPERBILIRUBINEMIA. , 1965, The Journal of clinical investigation.

[24]  G. Ekinci,et al.  Thalamic involvement in a patient with kernicterus , 2002, European Radiology.

[25]  Rui F. M. Silva,et al.  Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytes: role of concentration and pH. , 1999, Biochemical and biophysical research communications.

[26]  S. Oja,et al.  Taurine and neural cell damage , 2000, Amino Acids.

[27]  D. Enzmann,et al.  Kernicterus in a full term infant. , 1994, Pediatrics.

[28]  A. Brown,et al.  Erythrocyte metabolism and hemolysis in the newborn. , 1966, Pediatric clinics of North America.

[29]  Y. Eto,et al.  Magnetic resonance imaging in three children with kernicterus. , 2001, Pediatric neurology.

[30]  M. Taş,et al.  Henna-induced hemolytic anemia and acute renal failure. , 2001, The Turkish journal of pediatrics.